Moleculin to Report First Quarter Financial Results on May 11, 2023 and Host Conference Call and Webcast

HOUSTON, May 4, 2023 /PRNewswire/ -- Moleculin Biotech, Inc., , a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses,... | May 4, 2023

Related Keywords

Houston ,Texas ,United States ,Jonathan Foster ,Jenene Thomas ,Walter Klemp ,John Paul Waymack ,Facebook ,Nasdaq ,Linkedin ,Prnewswire Moleculin Biotech Inc ,Moleculin Biotech Inc ,Twitter ,Chief Executive Officer ,Financial Officer ,Senior Chief Medical Officer ,Moleculin Biotech Conference ,Moleculin Biotech ,Transcription Modulator ,Nc Stock Exchange ,News ,Information ,Press Release ,Bay ,023 ,Moleculin ,Linical ,Stage ,Harmaceutical ,Company ,Ith ,Road ,Portfolio ,F ,Drug ,Candidates ,Targeting ,Ighly ,Resistant ,Rumors ,Nd Mbrx Us60855d2009 ,